Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus

BACKGROUND: Low bone mineral density (BMD) is commonly observed in people living with HIV (PLWH), however the cause for this BMD loss remains unclear. Sclerostin, a bone-derived antagonist to the Wnt/β-catenin-pathway, suppresses bone remodeling and is positively associated with BMD. The goal of the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Bone Rep
Prif Awduron: Ross, Ryan D., Sharma, Anjali, Shi, Qiuhu, Hoover, Donald R., Weber, Kathleen M., Tien, Phyllis C., French, Audrey L., Al-Harthi, Lena, Yin, Michael T.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235609/
https://ncbi.nlm.nih.gov/pubmed/32455152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100279
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg